Skip to content
MedsAcross

Medicine

Levetiracetam 750 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Levetiracetam 750 mg tablet is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Levetiracetam
Brand
Sold under the generic name
Strength
750 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 120 tablets, 30 tablets and 65 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaTorrent PharmaceuticalsIndiaAscend LaboratoriesIndiaCamber PharmaceuticalsIndiaLupinIndiaAurobindo PharmaIndiaGranules IndiaIndiaNovadoz PharmaceuticalsIndiaSolco HealthcareCranbury Pharmaceuticals30 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AX14 Levetiracetam
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 November 2008
Identifiers
RxCUI 311288, 311289, 311290 +2DailyMed set ID 1c4450a1-6c05-4b45-a733-c19b4e861970, 28c0e61e-1af9-410a-9fa9-b71bf99a776b, dd713e60-478c-43cd-b680-ff594a0b3864 +30NDC 72205-096, 76282-248, 43547-223 +30Application ANDA214815, ANDA078234, ANDA078106 +12

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 30 labelers. The register lists 68 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
500 tablet, film coated in 1 bottle67877-770-05Ascend LaboratoriesIndia28 May 2022
120 tablet, film coated in 1 bottle67877-770-12Ascend LaboratoriesIndia28 May 2022
30 tablet, film coated in 1 bottle67877-770-30Ascend LaboratoriesIndia28 May 2022
1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-770-33Ascend LaboratoriesIndia28 May 2022
500 tablet, film coated in 1 bottle65862-247-05Aurobindo PharmaIndia15 January 2009
120 tablet, film coated in 1 bottle65862-247-08Aurobindo PharmaIndia15 January 2009
500 tablet, film coated in 1 bottle31722-538-05Camber PharmaceuticalsIndia8 October 2010
120 tablet, film coated in 1 bottle31722-538-12Camber PharmaceuticalsIndia8 October 2010
30 tablet, film coated in 1 bottle31722-538-30Camber PharmaceuticalsIndia8 October 2010
60 tablet, film coated in 1 bottle31722-538-60Camber PharmaceuticalsIndia8 October 2010
100 tablet in 1 bottle55111-183-01Dr. Reddy's LaboratoriesIndia15 January 2009
120 tablet in 1 bottle55111-183-04Dr. Reddy's LaboratoriesIndia15 January 2009
500 tablet in 1 bottle55111-183-05Dr. Reddy's LaboratoriesIndia15 January 2009
30 tablet in 1 bottle55111-183-30Dr. Reddy's LaboratoriesIndia15 January 2009
1 blister pack in 1 carton / 10 tablet in 1 blister pack55111-183-79Dr. Reddy's LaboratoriesIndia15 January 2009
30 tablet, film coated in 1 bottle70010-523-03Granules IndiaIndia24 June 2024
1000 tablet, film coated in 1 bottle70010-523-10Granules IndiaIndia24 June 2024
500 tablet, film coated in 1 bottle68180-114-02LupinIndia15 January 2009
90 tablet, film coated in 1 bottle68180-114-09LupinIndia15 January 2009
120 tablet, film coated in 1 bottle68180-114-16LupinIndia15 January 2009
120 tablet, film coated in 1 bottle, plastic72205-096-92Novadoz PharmaceuticalsIndia14 October 2022
500 tablet in 1 bottle13668-016-05Torrent PharmaceuticalsIndia15 January 2009
120 tablet in 1 bottle13668-016-12Torrent PharmaceuticalsIndia15 January 2009
250 tablet in 1 bottle13668-016-25Torrent PharmaceuticalsIndia15 January 2009
60 tablet in 1 bottle13668-016-60Torrent PharmaceuticalsIndia15 January 2009
800 tablet in 1 bottle13668-016-67Torrent PharmaceuticalsIndia15 January 2009
120 tablet, film coated in 1 bottle43547-223-15Solco Healthcare11 September 2012
120 tablet, film coated in 1 bottle43547-882-15Solco Healthcare1 September 2024
500 tablet, film coated in 1 bottle43547-882-50Solco Healthcare1 September 2024
120 tablet, film coated in 1 bottle65162-538-16Amneal Pharmaceuticals28 February 2013
120 tablet in 1 bottle27808-265-01Cranbury Pharmaceuticals1 May 2023
500 tablet in 1 bottle27808-265-02Cranbury Pharmaceuticals1 May 2023
120 tablet in 1 bottle76282-248-12Exelan Pharmaceuticals15 January 2009
500 tablet, film coated in 1 bottle, plastic0378-5617-05Mylan Pharmaceuticals4 November 2008
120 tablet, film coated in 1 bottle, plastic0378-5617-78Mylan Pharmaceuticals4 November 2008
120 tablet in 1 bottle69102-106-01OWP Pharmaceuticals28 October 2020
120 tablet, film coated in 1 bottle76494-530-12Prinston Pharmaceutical11 September 2012
120 tablet, film coated in 1 bottle64980-606-12Rising Pharma Holdings10 June 2024
500 tablet, film coated in 1 bottle64980-606-50Rising Pharma Holdings10 June 2024
500 tablet, film coated in 1 bottle50228-472-05ScieGen Pharmaceuticals11 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 November 1999Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Levetiracetam 750 mg tablet.

Compare 1

Other strengths and forms of Levetiracetam

Clinical summary

Levetiracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. MedsAcross supplies Levetiracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Levetiracetam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Levetiracetam 750 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.